IMMUNOSTEALTH Trademark

Trademark Overview

On Thursday, August 19, 2021, a trademark application was filed for IMMUNOSTEALTH with the United States Patent and Trademark Office. The USPTO has given the IMMUNOSTEALTH trademark a serial number of 90891747. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, August 27, 2024. This trademark is owned by Shoreline Biosciences, Inc.. The IMMUNOSTEALTH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development for medical cell-based immunotherapies and regenerative medicine; pharmaceutical immunotherapy and regenerative medicine drug development services; Providing information in the fields of regenerative medicine research and immunotherapy research; scientific study and research in the fields of immunotherapy research and regenerative medicine
immunostealth

General Information

Serial Number90891747
Word MarkIMMUNOSTEALTH
Filing DateThursday, August 19, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, August 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements

Goods and ServicesResearch and development for medical cell-based immunotherapies and regenerative medicine; pharmaceutical immunotherapy and regenerative medicine drug development services; Providing information in the fields of regenerative medicine research and immunotherapy research; scientific study and research in the fields of immunotherapy research and regenerative medicine

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 7, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameShoreline Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameShoreline Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, September 27, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 27, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 27, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 23, 2021NEW APPLICATION ENTERED
Thursday, October 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 20, 2022ASSIGNED TO EXAMINER
Saturday, November 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 31, 2022NON-FINAL ACTION WRITTEN
Tuesday, May 31, 2022NON-FINAL ACTION E-MAILED
Tuesday, May 31, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 23, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 21, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 21, 2024SOU EXTENSION 2 FILED
Wednesday, February 21, 2024SOU EXTENSION 2 GRANTED
Tuesday, February 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 28, 2023SOU TEAS EXTENSION RECEIVED
Monday, August 28, 2023SOU EXTENSION 1 FILED
Monday, August 28, 2023SOU EXTENSION 1 GRANTED
Thursday, February 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 27, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 27, 2024SOU EXTENSION 3 GRANTED
Tuesday, August 27, 2024SOU EXTENSION 3 FILED

Related Keywords

immunostealth research regenerative medicine immunotherapy fields development providing information study scientific